Skip to main content

Table 2 Plasma VLCFAs levels of five Chinese patients with Adrenomyeloneuropathy

From: Clinical, neuroimaging, biochemical, and genetic features in six Chinese patients with Adrenomyeloneuropathy

Patient

C22:0 (25.49–74.51 μmol/L)

C24:0 (20.85–61.50 μmol/L)

C26:0 (0.22–0.74 μmol/L)

C26:0/C22:0 (0.004–0.016)

C24:0/C22:0 (0.69–0.96)

1(before treated with Lorenzo’s oil)

42.5

62.3

1.12

0.09

1.63

1(after treated with Lorenzo’s oil)

10.1

14.8

0.76

0.16

1.56

2

49.1

102.4

2.81

0.057

2.09

3

40.8

66.8

1.21

0.070

2.00

4

30.2

58.4

1.48

0.049

1.93

6

38.0

70.0

2.34

0.062

1.84

  1. VLCFAs very long chain fatty acids